These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5488577)

  • 1. [Occurrence of antibodies against transcobalamin II in relation to the number of and the intervals between depot therapy with hydroxocobalamin].
    Hippe E; Olesen H; Skouby A
    Nord Med; 1970 Dec; 84(49):1570. PubMed ID: 5488577
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxocobalamin for initial and long-term therapy for vitamin B12 deficiency.
    Skouby AP
    Acta Med Scand; 1987; 221(4):399-402. PubMed ID: 3604755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of cyanocobalamin, hydroxocobalamin, and coenzyme B12 after parenteral administration.
    Boddy K; King P; Mervyn L; Macleod A; Adams JF
    Lancet; 1968 Sep; 2(7570):710-2. PubMed ID: 4175091
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimizing the dose of hydroxocobalamin in cobalamin C (cblC) defect.
    Dionisi-Vici C; Martinelli D; Ceravolo F; Boenzi S; Pastore A
    Mol Genet Metab; 2013 Aug; 109(4):329-30. PubMed ID: 23764205
    [No Abstract]   [Full Text] [Related]  

  • 5. Hydroxocobalamin and its long-acting effects in treatment of vitamin B 12 deficiency.
    Glass GB
    Pharmakotherapia; 1964; 2(1):21-58. PubMed ID: 5875718
    [No Abstract]   [Full Text] [Related]  

  • 6. Hereditary partial transcobalamin II deficiency with neurologic, mental and hematologic abnormalities in children and adults.
    Teplitsky V; Huminer D; Zoldan J; Pitlik S; Shohat M; Mittelman M
    Isr Med Assoc J; 2003 Dec; 5(12):868-72. PubMed ID: 14689755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxocobalamin and cyanocobalamin.
    Drug Ther Bull; 1966 Feb; 4(3):11-2. PubMed ID: 5905898
    [No Abstract]   [Full Text] [Related]  

  • 8. Retention and distribution of B12 activity, and requirement for B12, following parenteral administration of hydroxocobalamin (Vibeden).
    Skouby AP
    Acta Med Scand; 1966 Jul; 180(1):95-105. PubMed ID: 5940732
    [No Abstract]   [Full Text] [Related]  

  • 9. Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients.
    Slot WB; Merkus FW; Van Deventer SJ; Tytgat GN
    Gastroenterology; 1997 Aug; 113(2):430-3. PubMed ID: 9247460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxocobalamin for cobalamin C: which dosage?
    Wiwanitkit V
    J Inherit Metab Dis; 2010 Aug; 33(4):453; author reply 455. PubMed ID: 20224899
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyanocobalamin--a case for withdrawal.
    Reidenberg MM
    J R Soc Med; 1993 May; 86(5):309. PubMed ID: 8505762
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vitamin B deficiency].
    Hudson B
    Praxis (Bern 1994); 2010 Nov; 99(23):1435-6. PubMed ID: 21082597
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody to transcobalamin II and B12 binding capacity in patients treated with hydroxocobalamin.
    Skouby AP; Hippe E; Olesen H
    Blood; 1971 Dec; 38(6):769-74. PubMed ID: 5126165
    [No Abstract]   [Full Text] [Related]  

  • 14. Type I immediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin.
    Moloney FJ; Hughes R; O'Shea D; Kirby B
    Clin Exp Dermatol; 2008 Jul; 33(4):412-4. PubMed ID: 18498413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxocobalamin. V. Prolonged maintenance of high vitamin B12 blood levels following a short course of hydroxocobalamin injections.
    Glass GB; Skeggs HR; Lee DH
    Blood; 1966 Feb; 27(2):234-41. PubMed ID: 5322750
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dosage of hydroxocobalamin (Vibeden)].
    Skouby AP
    Ugeskr Laeger; 1970 Jan; 132(5):208-13. PubMed ID: 5446563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Macrocytic anemia in adults: physiopathology, etiology, diagnosis and treatment].
    Zittoun J
    Rev Prat; 1998 Apr; 48(8):899-904. PubMed ID: 11767337
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitamins and immunity. Vitamin B12 and folic acid].
    Pletsityĭ KD
    Vopr Pitan; 1993; (3):4-9. PubMed ID: 7975430
    [No Abstract]   [Full Text] [Related]  

  • 19. [An antibody against a vitamin B 12-binding serum protein (transcobalamin II). A cause of a high content of vitamin B 12 in the serum of patients treated with delayed-action B 12 preparations].
    Schwartz M; Hom B; Olesen H; Bastrup-Madsen P
    Ugeskr Laeger; 1968 May; 130(20):862-6. PubMed ID: 5723667
    [No Abstract]   [Full Text] [Related]  

  • 20. Unavailable hydroxocobalamin in injectable form.
    Antia PK
    J Indian Med Assoc; 1999 Jan; 97(1):25. PubMed ID: 10549186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.